Inside Precision Medicine June 4, 2024
Laura Cowen

Julia Vitarello is on a personal mission to open up access to individualized therapies for people with rare diseases, starting in the U.K. with the government-backed Rare Therapies Launch Pad

In recent years, whole genome sequencing has made it easier to diagnose rare genetic diseases while scientific advances have put individualized treatments within reach. Yet, the regulatory processes, typically designed for large-scale drug production, are lagging behind. This, combined with limited funding and a lack of awareness, makes it painfully difficult for people with rare diseases to access the life-saving therapies they so desperately need. Julia Vitarello is hoping to change this.

Mila’s story

Ten years ago, Julia had very little knowledge of genetic diseases, she also had no idea...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine
Shifting the Paradigm in Whole-Genome Sequencing for Newborns

Share This Article